Banghui Mo
Impact in
-
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
-
- Signaling Pathways in Disease 1
- Protein Degradation and Inhibitors 1
-
- Ferroptosis and cancer prognosis 4
- Co-authors
- Songtao Yu (6 shared papers)Shenglin Luo (7 shared papers)Youcai Deng (3 shared papers)Lian Li (2 shared papers)Xiaojiao Wang (2 shared papers)Weidong Wang (3 shared papers)Mingquan Gao (4 shared papers)Rong Li (3 shared papers)
- Journals
- Advanced Healthcare Materials (2 papers)Journal of Cancer (1 paper)Pharmaceuticals (1 paper)Nature Communications (1 paper)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Banghui Mo
12 papers receiving 318 citations
Peers
Comparison fields: 5 of 65
- Immunology 112
- Cancer Research 57
- Oncology 64
- Pulmonary and Respiratory Medicine 68
- Biomedical Engineering 90
Countries citing papers authored by Banghui Mo
This map shows the geographic impact of Banghui Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banghui Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banghui Mo more than expected).
Fields of papers citing papers by Banghui Mo
This network shows the impact of papers produced by Banghui Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banghui Mo. The network helps show where Banghui Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Banghui Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 91 | |
| 2 | 2023 | 58 | |
| 3 | 2020 | 39 | |
| 4 | 2018 | 36 | |
| 5 | 2023 | 30 | |
| 6 | 2020 | 28 | |
| 7 | 2022 | 25 | |
| 8 | 2021 | 5 | |
| 9 | 2024 | 3 | |
| 10 | 2025 | 2 | |
| 11 | 2025 | 2 | |
| 12 | 2023 | 1 |
About Banghui Mo
Banghui Mo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering, Immunology and Oncology, having authored 12 papers that have together received 320 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Ferroptosis and cancer prognosis (4 papers), Phagocytosis and Immune Regulation (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Signaling Pathways in Disease (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Immunology (112 citations), Cancer Research (57 citations), Oncology (64 citations), Pulmonary and Respiratory Medicine (68 citations) and Biomedical Engineering (90 citations). Banghui Mo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Songtao Yu, Shenglin Luo, Youcai Deng, Lian Li, Xiaojiao Wang, Weidong Wang, Mingquan Gao, Rong Li, Xiaoyuan Gong and Lilin Ye. Their work appears in journals such as Advanced Healthcare Materials, Journal of Cancer, Pharmaceuticals, Nature Communications and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.